N = 103 COVID-19 patients with severe ARDS, hypoxemia or life-threatening organ failure  Intervention group: patients receiving CP in addition to standard treatment (n = 52)  Control group: patients receiving standard treatment alone (n = 51). This evidence concerns the gene CP and COVID-19.